Otsuka receive CRL from US FDA for sNDA of Rexulti in combination with sertraline to treat adults with post-traumatic stress disorder: Japan Monday, September 22, 2025, 10:00 Hrs ...
MAHE Centre for cGMP sets the tone for 3rd National cGMP Day on Oct 10 where revised Schedule M compliance takes centre stage: Our Bureau, Bengaluru Monday, September 22, 2025, 09 ...
NPPA releases draft calculation sheet with ceiling price of six scheduled formulations: Gireesh Babu, New Delhi Monday, ...
DGTR reschedules hearing in anti-dumping probe on EDA imports from China, EU, Saudi Arabia & Taiwan: Shardul Nautiyal, Mumbai Monday, September 22, 2025, 08:00 Hrs [IST] The Direc ...
New B. Pharm syllabus will create globally competitive professionals: experts: Nandita Vijayasimha, Bengaluru Monday, September 22, 2025, 08:00 Hrs [IST] In a bold move to align p ...
Pharma MSMEs warn of nationwide protest against difficult regulatory environment: Peethaambaran Kunnathoor, Chennai Monday, September 22, 2025, 08:00 Hrs [IST] In a move highlight ...
Digital diagnostics shaping new standards in global treatment protocols: Expert: Nandita Vijayasimha, Bengaluru Monday, September 22, 2025, 08:00 Hrs [IST] The healthcare industry ...
India currently has the largest pharmacovigilance programme in the world, and it is time to integrate pharmacovigilance with technology and other innovative fields, said experts during the inaugural ...
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced that its unidose liquid system is the delivery system for the recent US FDA-approved ...
Kairos Pharma announces positive interim efficacy analysis from phase 2 clinical trial of ENV105: Los Angeles, California Saturday, September 20, 2025, 17:00 Hrs [IST] Los Angeles ...
Merck receives two positive EU CHMP opinions for Keytruda for SC administration and for new indication for earlier-stage head and neck cancer: Rahway, New Jersey Saturday, Septemb ...
Infinimmune, a biotechnology company pioneering a novel approach to antibody drug discovery and development, announced a research collaboration agreement with Immunome Inc, a clinical-stage targeted ...